Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate (Q35760136)

From Wikidata
Jump to navigation Jump to search
scientific article published on 19 December 2006
edit
Language Label Description Also known as
English
Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate
scientific article published on 19 December 2006

    Statements

    Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit